Home Mf Research Nippon India Pharma Fund
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI
Fund info
NAV (as on 2026-02-20)
₹505.88 -0.03%
AUM (Fund Size)
N/A
Expense Ratio
1.82%
Exit load
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units; Nil, thereafter.
Risk
N/A
AMC
NIPPON INDIA MUTUAL FUND
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-02-13 ₹1,000.00 ₹1,006.70
0.67 %
Two Week 2026-02-05 ₹1,000.00 ₹1,017.89
1.79 %
One Month 2026-01-21 ₹1,000.00 ₹1,039.18
3.92 %
Three Months 2025-11-24 ₹3,000.00 ₹3,017.08
0.57 %
Six Months 2025-08-25 ₹6,000.00 ₹5,941.66
-0.97 %
One Year 2025-02-20 ₹12,000.00 ₹11,998.81
-0.01 %
Three Year 2023-02-21 ₹36,000.00 ₹43,847.65
21.80 %
Five Year 2021-02-22 ₹60,000.00 ₹86,866.58
44.78 %
Ten Year 2016-02-23 ₹120,000.00 ₹292,366.25
143.64 %
Since Inception 2004-06-05 ₹265,000.00 ₹2,744,362.85
935.61 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Nippon India Pharma Fund

Healthcare Services
13%
Pharmaceuticals & Biotechnology
65%
Retailing
3%
Unknown
1%

Companies Holding in Nippon India Pharma Fund

Apollo Hospitals Enterprise Limited
5.14%
Vijaya Diagnostic Centre Limited
3.41%
Narayana Hrudayalaya Limited
2.84%
Thyrocare Technologies Limited
1.59%
Fortis Healthcare Limited
1.33%
Suraksha Diagnostic Limited
1.09%
Sun Pharmaceutical Industries Limited
13.68%
Divi's Laboratories Limited
9.32%
Lupin Limited
7.73%
Cipla Limited
5.90%
Dr. Reddy's Laboratories Limited
5.35%
Abbott India Limited
3.82%
GlaxoSmithKline Pharmaceuticals Limited
3.28%
Ajanta Pharma Limited
3.12%
Gland Pharma Limited
3.11%
Aurobindo Pharma Limited
2.36%
Zydus Lifesciences Limited
2.30%
JB Chemicals & Pharmaceuticals Limited
2.15%
Mankind Pharma Limited
1.95%
Torrent Pharmaceuticals Limited
1.94%
Pfizer Limited
1.69%
Alkem Laboratories Limited
1.69%
Sanofi India Limited
1.51%
IPCA Laboratories Limited
1.39%
Sanofi Consumer Healthcare India Limited
1.27%
Sai Life Sciences Limited
1.22%
MedPlus Health Services Limited
3.39%
Cash And Other Receivables
1.11%

Risk Ratios

Std. Deviation 14.28
Beta 0.88
Sharpe Ratio 0.48
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
1.82
Expense Ratio Direct
0.92
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Sailesh Raj Bhan
29 years Experience

Exit load

1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units; Nil, thereafter.

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?